The future of healthcare lies at the intersection of empathy and innovation, where artificial intelligence empowers—not replaces—the human touch. At QurHealth, we’re transforming this vision into reality with Sheela, our AI-driven care platform designed to deliver truly personalized, data-informed support throughout every stage of a patient’s journey. Born from a clinician’s firsthand experience with a fragmented system, Sheela bridges critical gaps in care through real-time insights, intelligent engagement, and culturally sensitive communication. As we scale across health systems and communities, Sheela is proving that AI, when guided by clinical expertise and patient needs, can drive better outcomes, improve equity, and make healthcare more proactive, predictive, and deeply human.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.